Search Results - "Piccirillo, M M"

Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics by Sottoriva, Andrea, Spiteri, Inmaculada, Piccirillo, Sara G. M., Touloumis, Anestis, Collins, V. Peter, Marioni, John C., Curtis, Christina, Watts, Colin, Tavaré, Simon

“…Glioblastoma (GB) is the most common and aggressive primary brain malignancy, with poor prognosis and a lack of effective therapeutic options. Accumulating…”
Get full text

Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients by Wagner, U, Marth, C, Largillier, R, Kaern, J, Brown, C, Heywood, M, Bonaventura, T, Vergote, I, Piccirillo, M C, Fossati, R, Gebski, V, Lauraine, E P

“…Background: The CALYPSO phase III trial compared CD (carboplatin-pegylated liposomal doxorubicin (PLD)) with CP (carboplatin-paclitaxel) in patients with…”
Get full text

High frequency of mosaic pathogenic variants in genes causing epilepsy-related neurodevelopmental disorders by Stosser, Mary Beth, Lindy, Amanda S, Butler, Elizabeth, Retterer, Kyle, Piccirillo-Stosser, Caitlin M, Richard, Gabriele, McKnight, Dianalee A

“…Purpose Mosaicism probably represents an underreported cause of genetic disorders due to detection challenges during routine molecular diagnostics. The purpose…”
Get full text

The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy by Perrone, F., Jommi, C., Di Maio, M., Gimigliano, A., Gridelli, C., Pignata, S., Ciardiello, F., Nuzzo, F., de Matteis, A., Del Mastro, L., Bryce, J., Daniele, G., Morabito, A., Piccirillo, M.C., Rocco, G., Guizzaro, L., Gallo, C.

“…Financial difficulties, measured by the EORTC C30 questionnaire, were associated with worse quality of life and shorter overall survival of cancer patients…”
Get full text

Electrochemotherapy in locally advanced pancreatic cancer: Preliminary results by Granata, V, Fusco, R, Piccirillo, M, Palaia, R, Petrillo, A, Lastoria, S, Izzo, F

“…Abstract Objective Report the preliminary results on electrochemotherapy (ECT) in the treatment of locally advanced pancreatic cancer of a phase I/II study and…”
Get full text

Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution by Piccirillo, S G M, Combi, R, Cajola, L, Patrizi, A, Redaelli, S, Bentivegna, A, Baronchelli, S, Maira, G, Pollo, B, Mangiola, A, DiMeco, F, Dalprà, L, Vescovi, A L

“…Glioblastomas (GBMs) contain transformed, self-maintaining, multipotent, tumour-initiating cancer stem cells, whose identification has radically changed our…”
Get full text

Extensive 200-Million-Year-Old Continental Flood Basalts of the Central Atlantic Magmatic Province by Marzoli, Andrea, Renne, Paul R., Piccirillo, Enzo M., Ernesto, Marcia, Bellieni, Giuliano, de Min, Angelo

“…The Central Atlantic Magmatic Province (CAMP) is defined by tholeiitic basalts that crop out in once-contiguous parts of North America, Europe, Africa, and…”
Get full text

Astrocytic stress response is induced by exposure to astrocyte-binding antibodies expressed by plasmablasts from pediatric patients with acute transverse myelitis by Smith, Chad, Telesford, Kiel M, Piccirillo, Sara G M, Licon-Munoz, Yamhilette, Zhang, Wei, Tse, Key M, Rivas, Jacqueline R, Joshi, Chaitanya, Shah, Dilan S, Wu, Angela X, Trivedi, Ritu, Christley, Scott, Qian, Yu, Cowell, Lindsay G, Scheuermann, Richard H, Stowe, Ann M, Nguyen, Linda, Greenberg, Benjamin M, Monson, Nancy L

“…Pediatric acute transverse myelitis (ATM) accounts for 20-30% of children presenting with a first acquired demyelinating syndrome (ADS) and may be the first…”
Get full text

Induction of VX2 para-renal carcinoma in rabbits: generation of animal model for loco-regional treatments of solid tumors by Bimonte, S, Leongito, M, Piccirillo, M, Izzo, F

Get full text

Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trial by Nasti, G, Piccirillo, M C, Izzo, F, Ottaiano, A, Albino, V, Delrio, P, Romano, C, Giordano, P, Lastoria, S, Caracò, C, de Lutio di Castelguidone, E, Palaia, R, Daniele, G, Aloj, L, Romano, G, Iaffaioli, R V

“…Background: Preoperative treatment of resectable liver metastases from colorectal cancer (CRC) is a matter of debate. The aim of this study was to assess the…”
Get full text

Electrochemotherapy of cholangiocellular carcinoma at hepatic hilum: a case report by Granata, V, Palaia, R, Albino, V, Piccirillo, M, Venanzio Setola, S, Petrillo, A, Izzo, F

“…Cholangiocarcinoma (CCA) is the second most common primary hepatic malignancy after hepatocellular carcinoma. The current standard palliative treatment,…”
Get more information

Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial by Perrone, F., Nuzzo, F., Di Rella, F., Gravina, A., Iodice, G., Labonia, V., Landi, G., Pacilio, C., Rossi, E., De Laurentiis, M., D'Aiuto, M., Botti, G., Forestieri, V., Lauria, R., De Placido, S., Tinessa, V., Daniele, B., Gori, S., Colantuoni, G., Barni, S., Riccardi, F., De Maio, E., Montanino, A., Morabito, A., Daniele, G., Di Maio, M., Piccirillo, M.C., Signoriello, S., Gallo, C., de Matteis, A.

“…Evidence on adjuvant chemotherapy for elderly early breast cancer patients is poor, due to the low number of phase 3 trials. ELDA shows that weekly docetaxel…”
Get full text

Bevacizumab in non small cell lung cancer: development, current status and issues by Sandomenico, C, Costanzo, R, Carillio, G, Piccirillo, M C, Montanino, A, Di Maio, M, Rocco, G, Normanno, N, Perrone, F, Morabito, A

“…Bevacizumab is a monoclonal antibody directed against Vascular Endothelial Growth Factor (VEGF). Evidence about its efficacy in addition to first-line…”
Get more information

The HOBOE-2 multicenter randomized phase III trial in premenopausal patients with hormone-receptor positive early breast cancer comparing triptorelin plus either tamoxifen or letrozole or letrozole + zoledronic acid by Perrone, F., De Laurentiis, M., de Placido, S., Orditura, M., Cinieri, S., Riccardi, F., Ribecco, A.S., Putzu, C., Del Mastro, L., Rossi, E., Daniele, B., Mosconi, A.M., Di Rella, F., Landi, G., Nuzzo, F., Pacilio, C., Lauria, R., Arenare, L., Piccirillo, M.C., Gallo, C.

Get full text

Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials by Arenare, L., Di Liello, R., De Placido, P., Gridelli, C., Morabito, A., Pignata, S., Nuzzo, F., Avallone, A., Maiello, E., Gargiulo, P., Schettino, C., Gravina, A., Gallo, C., Chiodini, P., Di Maio, M., Perrone, F., Piccirillo, M.C.

“…Oncologists tend to under-report subjective symptoms during cancer treatment. This study describes the under-reporting rate of selected symptoms and explores…”
Get full text

Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer by Piccirillo, M.C., Scambia, G., Bologna, A., Signoriello, S., Vergote, I., Baumann, K., Lorusso, D., Murgia, V., Sorio, R., Ferrandina, G., Sacco, C., Cormio, G., Breda, E., Cinieri, S., Natale, D., Mangili, G., Pisano, C., Cecere, S.C., Di Napoli, M., Salutari, V., Raspagliesi, F., Arenare, L., Bergamini, A., Bryce, J., Daniele, G., Gallo, C., Pignata, S., Perrone, F.

“…MITO-8 showed that prolonging platinum-free interval by introducing non-platinum-based chemotherapy (NPBC) does not improve prognosis of patients with…”
Get full text

Phase I/II study of valproic acid (VPA) and short-course radiotherapy (SCRT) plus capecitabine (CAP) as preoperative treatment in low-moderate risk rectal cancer (V-shoRT-R3) by Budillon, A, Delrio, P, Pecori, B, Tatangelo, F, Di Gennaro, E, Romano, C, D'Angelo, V, Marone, P, Granata, C, Cavalacanti, E, De Stefano, A, Pace, U, Bianco, F, Petrillo, A, Lastoria, S, Botti, G, Muto, P, Perrone, F, Piccirillo, M C, Avallone, A

Get full text

Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE study by Nuzzo, F., Gallo, C., Lastoria, S., Di Maio, M., Piccirillo, M.C., Gravina, A., Landi, G., Rossi, E., Pacilio, C., Labonia, V., Di Rella, F., Bartiromo, A., Buonfanti, G., De Feo, G., Esposito, G., D'Aniello, R., Maiolino, P., Signoriello, S., De Maio, E., Tinessa, V., Colantuoni, G., De Laurentiis, M., D'Aiuto, M., Di Bonito, M., Botti, G., Giordano, P., Daniele, G., Morabito, A., Normanno, N., de Matteis, A., Perrone, F.

“…To measure bone mineral density (BMD) reduction produced by letrozole as compared with tamoxifen and the benefit of the addition of zoledronic acid. A phase 3…”
Get full text

Performance Comparison of a Pretied Suture Knot With Three Conventional Arthroscopic Knots by Rodes, Stephen A., M.D, Favorito, Paul J., M.D, Piccirillo, Justin M., M.S, Spivey, James T., M.B.A

“…Purpose To compare the knot characteristics of a pretied suture knot with 3 of the most commonly used arthroscopic knots tied with various high-strength…”
Get full text

Survival analysis of a multicentre, randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in patients with metastatic colorectal cancer (mCRC) by Avallone, A., Nasti, G., Rosati, G., Carlomagno, C., Romano, C., Bilancia, D., De Stefano, A., Silvestro, L., Ottaiano, A., Cassata, A., Bianco, F., Izzo, F., Delrio, P., De Gennaro, E., Casaretti, R., Tafuto, S., Albino, V., Pace, U., Lastoria, S., Gallo, C., Budillon, A., Piccirillo, M.

Get full text